About the Authors
- Ian R. Peak
-
Contributed equally to this work with: Ian R. Peak, Yogitha N. Srikhanta
Affiliation Institute for Glycomics, Griffith University, Gold Coast Campus, Gold Coast, Queensland, Australia
- Yogitha N. Srikhanta
-
Contributed equally to this work with: Ian R. Peak, Yogitha N. Srikhanta
Current address: Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Victoria, Australia
Affiliation School of Molecular and Microbial Science, The University of Queensland, Brisbane, Queensland, Australia
- Vincent E. Weynants
-
Affiliation GlaxoSmithKline Vaccines, Rixensart, Belgium
- Christiane Feron
-
Affiliation GlaxoSmithKline Vaccines, Rixensart, Belgium
- Jan T. Poolman
-
Current address: Crucell, Leiden, Holland
Affiliation GlaxoSmithKline Vaccines, Rixensart, Belgium
- Michael P. Jennings
-
* E-mail: m.jennings@griffith.edu.au
Affiliation Institute for Glycomics, Griffith University, Gold Coast Campus, Gold Coast, Queensland, Australia
Competing Interests
VEW, CF, and JTP are employees of GlaxoSmithKline. JTP was an employee of GSK at the at the time of the study. IRP and MPJ are named inventors on patents relating to this work and therefore have a potential financial interest. The current or former employment of authors, or potential interest through patent inventorships of authors does not alter our adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: IRP MPJ JTP. Performed the experiments: IRP YNS VEW CF. Wrote the paper: IRP MPJ VEW.